0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Epigenetic Regulation of Keap1-Nrf2 Signaling

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The kelch-like ECH-associated protein 1 (Keap1)-nuclear factor erythroid 2-related factor 2 (Nrf2) signaling axis serves as a “master regulator” in response to oxidative/electrophilic stresses and chemical insults through the coordinated induction of a wide array of cytoprotective genes. Therefore, activation of Nrf2 is considered to be an important approach for preventing chronic diseases triggered by stresses and toxins, including cancer. Despite extensive studies suggested that the Keap1-Nrf2 signaling pathway is subject to multiple layers of regulation at the transcriptional, translational, and post-translational levels, the potential epigenetic regulation of Nrf2 and Keap1 has begun to be recognized only in recent years. Epigenetic modifications, heritable alterations in gene expression that occur without changes in the primary DNA sequence, have been reported to be profoundly involved in oxidative stress responses. In this review, we discuss the latest findings regarding the epigenetic regulation of Keap1-Nrf2 signaling by DNA methylation, histone modification, and microRNAs. The crosstalk among these epigenetic modifications in the regulation of Keap1-Nrf2 signaling pathways is also discussed. Studies of the epigenetic modification of Nrf2 and Keap1 have not only enhanced our understanding of this complex cellular defense system but have also provided potential new therapeutic targets for the prevention of certain diseases.

          Related collections

          Author and article information

          Journal
          8709159
          3902
          Free Radic Biol Med
          Free Radic. Biol. Med.
          Free radical biology & medicine
          0891-5849
          1873-4596
          15 July 2016
          25 June 2015
          November 2015
          01 November 2016
          : 88
          : Pt B
          : 337-349
          Affiliations
          [a ]Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ, 08854, USA
          [b ]State Key Laboratory of Natural and Biomimetic Drugs, and Peking University School of Pharmaceutical Sciences, Beijing, P.R. China, 100191
          Author notes
          [* ]Correspondence should be addressed to: Dr. Siwang Yu, Peking University School of Pharmaceutical Sciences, Room 308, 38 Xueyuan Road, Beijing, 100191, Phone: +86-10-82801539, swang_yu@ 123456bjmu.edu.cn ; Professor Ah-Ng Tony Kong, Ernest Mario School of Pharmacy, Room 228, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854, Phone: +1-848-445-6369/8, Fax: +1 732 445 3134, kongt@ 123456pharmacy.rutgers.edu
          Article
          PMC4955581 PMC4955581 4955581 nihpa802925
          10.1016/j.freeradbiomed.2015.06.013
          4955581
          26117320
          189bdb69-b8e4-4207-ae09-ba1a20b11a81
          History
          Categories
          Article

          Nrf2,microRNAs,histone modification,DNA methylation,Epigenetic,Keap1

          Comments

          Comment on this article